• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

essential tremor

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Praxis plots path to FDA after phase 3 wins in essential tremor

The trials demonstrated the benefits of ulixacaltamide in essential tremor after a previously grim outlook from one study earlier this year.
Zoey Becker Oct 16, 2025 11:48am
New CEO executive boardroom leader

Encora names CEO as co-founder, and previous chief takes VP role

Oct 7, 2025 9:30am
A nurse holding the hands of an elderly patient

FDA clears Fasikl AI stimulation wristwatch for essential tremor

Jul 3, 2025 9:15am
success failure signposts

Praxis moves ahead despite phase 3 tremor trial futility finding

Feb 28, 2025 9:11am
Elderly patient old old age alzheimers parkinsons assisted living hospice

Cala raises $50M to boost its wearable hand tremor therapy

Dec 9, 2024 10:58am
Brain and money connected by a thread on a white background

Acadia inks $582M biobucks pact for Danish biotech's neuro asset

Nov 26, 2024 5:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings